BIIB059   Click here for help

GtoPdb Ligand ID: 11122

Immunopharmacology Ligand
Compound class: Antibody
Comment: BIIB059 is a fully humanized IgG1, clinical stage CLEC4C (BDCA2) targeting monoclonal antibody. It is being evaluated for ability to reduce release of disease-driving interferons (principally IFN-α) in SLE. BIIB059 was developed by Biogen, based on prior evidence of target engagement and SLE-applicable immunomodulatory efficacy of a humanized mAb against BDCA2 named 24F4A [2].
Classification Click here for help
Compound class Antibody
Database Links Click here for help
GtoPdb PubChem SID 434122182